Stellular Bio Secures Series 1 Financing to Enhance Ocular Disease Treatment Stellular Bio announces the closure of Series 1 financing aimed at advancing its groundbreaking platelet-derived therapy for Sjogren's disease.

Stellular Bio Secures Series 1 Financing to Enhance Ocular Disease Treatment #United_States #regenerative_medicine #Watertown #Sjögren's_Disease #Stellular_Bio